Product image of Itraconazol Altan (Itraconazole) supplied by GNH India

Itraconazol Altan

Active Ingredient:
Itraconazole
Origin:
EU

Itraconazol Altan (Itraconazole)

Itraconazole, the active ingredient in Itraconazol Altan, is a azole antifungal presented as a intravenous infusion solution for intravenous infusion use. It treats invasive fungal infections such as aspergillosis, candidemia and other systemic mycoses in immunocompromised patients.

GNH India supplies Itraconazol Altan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable quality and regulatory compliance for critical care settings. The product meets EU pharmacopeial standards and is manufactured under GMP conditions.

Manufacturer / TM Owner

Altan Pharmaceuticals S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Itraconazole is an azole antifungal used to treat systemic fungal infections by inhibiting ergosterol synthesis.

  • Invasive aspergillosis: effective for treatment of life‑threatening lung and disseminated infections caused by Aspergillus species.
  • Candidiasis (including candidemia): used to clear bloodstream and deep‑tissue Candida infections.
  • Blastomycosis: indicated for severe blastomyces infections affecting lungs and other organs.
  • Histoplasmosis: employed in disseminated disease and severe pulmonary involvement.
  • Sporotrichosis: treats deep or disseminated Sporothrix infections resistant to oral therapy.

How It Works

  • Itraconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform, preventing conversion of lanosterol to ergosterol. This depletion of ergosterol disrupts fungal cell membrane integrity and impairs growth, leading to fungistatic or fungicidal activity against a broad spectrum of yeasts and molds.

Side Effects

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Vomiting: occasional episodes during infusion.
  • Abdominal pain: discomfort in the upper abdomen.
  • Headache: transient headache during or after infusion.
  • Rash: mild skin erythema or pruritus.
  • Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects

  • Hepatotoxicity: severe liver injury requiring monitoring.
  • Severe hypersensitivity reactions: including anaphylaxis.
  • Cardiac failure: worsening of pre‑existing heart conditions.
  • Visual disturbances: blurred vision or photophobia.
  • QT prolongation: risk of arrhythmias, especially with other QT‑prolonging drugs.

Precautions & Warnings

Precautions for Itraconazol Altan include careful patient assessment and monitoring.

  • Liver function monitoring: assess baseline and periodic LFTs during therapy.
  • Drug interactions: review concomitant medications for CYP3A4 substrates or inhibitors.
  • Cardiac status: avoid in patients with known heart failure.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Itraconazol Altan may interact with several medicines; clinicians should assess risk.

Major Interactions (Avoid)

  • Rifampin: induces metabolism, markedly lowers itraconazole exposure.
  • Ketoconazole: competitive inhibition can raise itraconazole concentrations and toxicity.
  • Drugs that prolong QT interval (e.g., quinidine, sotalol): increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

  • Macrolide antibiotics (e.g., erythromycin, clarithromycin): may increase itraconazole levels.
  • CYP3A4 substrates (e.g., midazolam, sirolimus): require dose adjustment and monitoring.

Frequently Asked Questions

Itraconazol Altan is indicated for severe systemic fungal infections such as invasive aspergillosis, candidemia, blastomycosis, histoplasmosis, and sporotrichosis. It is administered intravenously to patients who need rapid, reliable antifungal therapy, especially when oral options are unsuitable or ineffective.

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By preventing ergosterol formation, the drug disrupts the integrity of the fungal cell membrane, inhibiting growth and leading to fungal cell death or stasis.

The dosage of Itraconazol Altan is determined by the prescribing clinician based on the specific infection, severity, patient weight, renal and hepatic function, and other clinical factors. Only a qualified healthcare professional should set the infusion rate and total daily amount.

Safety data for itraconazole in pregnancy and lactation are limited. It should be used only when the potential benefit justifies the potential risk to the fetus or infant. Clinicians must evaluate each case individually and discuss possible risks with the patient.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other azole antifungals, itraconazole offers a broad spectrum against both yeasts and molds and is available as an IV formulation for rapid systemic exposure. It may have fewer drug‑interaction concerns than some newer agents but requires careful monitoring of liver function and cardiac status.

Itraconazol Altan should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the solution in its original container until use, and discard any product that appears discolored or particulate.

The product is given as an intravenous infusion. The infusion rate and total daily dose are set by the treating physician, typically administered over a specified period under clinical supervision to ensure proper plasma concentrations and minimize adverse reactions.

Serious risks include hepatotoxicity, severe hypersensitivity reactions such as anaphylaxis, cardiac failure in susceptible patients, visual disturbances, and QT‑interval prolongation that can lead to arrhythmias, especially when combined with other QT‑prolonging drugs.

Patients with known hypersensitivity to itraconazole or any component of the formulation should avoid the product. It is also contraindicated in individuals with uncontrolled heart failure, severe hepatic impairment, or those taking medications that strongly prolong the QT interval without close monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.